08/11/2014 - 12:09pm

Janssen Pharmaceuticals received approval from the Food and Drug Administration for Invokamet, a fixed-dose therapy that combines canagliflozin and metformin hydrochloride in a single tablet.

08/11/2014 - 11:34am

The Food and Drug Administration last week released a draft guidance to assist sponsors and other interested parties in providing information that will help the agency determine the exclusivity period for biologics approved under Section 351(a) of the Public Health Service Act, Bloomberg BNA reported.

08/11/2014 - 11:15am

Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million. 

08/11/2014 - 9:53am

Mylan announced the launch of capecitabine tablets USP in 150-mg and 500-mg dosage strengths, a generic version of Xeloda tablets from Genentech.

08/08/2014 - 2:33pm

The Food and Drug Administration earlier this week announced approval for Orbactiv (oritavancin), an antibacterial drug used to treat patients with acute bacterial skin and skin structure infections.

08/08/2014 - 1:51pm

Several NACDS chain member companies have conducted congressional pharmacy tours in recent weeks, bringing the total number of NACDS RxImpact in-district events to 82 for 2014.

08/08/2014 - 11:39am

The BBC on Tuesday reported that a team has developed an app and small lens add-on that allows blood-cell analysis via a smartphone.

08/08/2014 - 11:26am

Diplomat on Thursday announced that its president, Gary Kadlec, has been elected to the board of directors for the American Foundation of Pharmaceutical Education. 

08/07/2014 - 12:05pm

A new experimental drug to treat Ebola has been tried in the two American patients being treated in an Atlanta hospital, The New York Times reported Wednesday